The role of FERMT2 in AD and tauopathy is largely unknown, but a genome-wide siRNA screen suggested that FERMT2 may increase Aβ peptide production by elevating the levels of mature APP at the cell surface via membrane recycling [44]. The gene discussed is APP; the disease is Alzheimer disease.